Sam94的个人主页 - 老虎社区

Sam94

Sam94

暂无个人介绍

IP属地：未知

6关注

3粉丝

0主题

0勋章

2021-10-11

Good read

3 Stocks Wall Street Thinks Will Soar 44% to 122% That You'll Want to Check Out

2021-09-28

$PayPal(PYPL)$paypal

2021-09-28

Cool

Pharmaceutical stocks slid in morning trading

2021-10-19

$PayPal(PYPL)$paypal

2021-10-26

Intel

Why Intel is in turnaround mode

2021-10-23

Good read

@WallStreet_Tiger:Top 10 Stocks Popular on WallStreetBets 10/21: PYPL Explores AcquisItion Of PINS

2021-10-16

$PayPal(PYPL)$Finally turn green

2021-10-11

Nio

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4090586973979210","uuid":"4090586973979210","gmtCreate":1627483932880,"gmtModify":1632839569424,"name":"Sam94","pinyin":"sam94","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":6,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":852316638,"gmtCreate":1635242090169,"gmtModify":1635242090285,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"Intel&nbsp;","listText":"Intel&nbsp;","text":"Intel","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852316638","repostId":"2178747335","repostType":4,"isVote":1,"tweetType":1,"viewCount":918,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858335995,"gmtCreate":1634976866832,"gmtModify":1634976866997,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"Good read&nbsp;","listText":"Good read&nbsp;","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/858335995","repostId":"853891088","repostType":1,"repost":{"id":853891088,"gmtCreate":1634785574941,"gmtModify":1634987426529,"author":{"id":"9000000000000419","authorId":"9000000000000419","name":"WallStreet_Tiger","avatar":"https://static.tigerbbs.com/eb8b72f48dd1c8d3451a5d8f8a51f42e","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000419","authorIdStr":"9000000000000419"},"themes":[],"title":"Top 10 Stocks Popular on WallStreetBets 10/21: PYPL Explores AcquisItion Of PINS","htmlText":"These&nbsp;10&nbsp;stocks&nbsp;are&nbsp;the&nbsp;most&nbsp;popular&nbsp;on&nbsp;WallStreetBets&nbsp;for&nbsp;the&nbsp;last&nbsp;24&nbsp;hours: <a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a> posted third-quarter profitsthat topped expectations, with record deliveries helping fuel the electric-vehicle maker's results even as supply chain challenges weighed broadly on the auto industry. However, quarterly revenue came in short of consensus expectations, and shares fell slightly in after-hours trading.&nbsp; <a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a> has offered to buy digital pinboard site Pinterest Inc&nbsp;<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a> for $45 billion, according&nbsp;to&nbsp;the&nbsp;report on Wednesday, a combination that could he","listText":"These&nbsp;10&nbsp;stocks&nbsp;are&nbsp;the&nbsp;most&nbsp;popular&nbsp;on&nbsp;WallStreetBets&nbsp;for&nbsp;the&nbsp;last&nbsp;24&nbsp;hours: <a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a> posted third-quarter profitsthat topped expectations, with record deliveries helping fuel the electric-vehicle maker's results even as supply chain challenges weighed broadly on the auto industry. However, quarterly revenue came in short of consensus expectations, and shares fell slightly in after-hours trading.&nbsp; <a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a> has offered to buy digital pinboard site Pinterest Inc&nbsp;<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a> for $45 billion, according&nbsp;to&nbsp;the&nbsp;report on Wednesday, a combination that could he","text":"These 10 stocks are the most popular on WallStreetBets for the last 24 hours: $Tesla Motors(TSLA)$ posted third-quarter profitsthat topped expectations, with record deliveries helping fuel the electric-vehicle maker's results even as supply chain challenges weighed broadly on the auto industry. However, quarterly revenue came in short of consensus expectations, and shares fell slightly in after-hours trading. $PayPal(PYPL)$ has offered to buy digital pinboard site Pinterest Inc $Pinterest, Inc.(PINS)$ for $45 billion, according to the report on Wednesday, a combination that could he","images":[{"img":"https://static.tigerbbs.com/42d3767093c342b8608d28d9df362c09","width":"-1","height":"-1"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/853891088","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850562715,"gmtCreate":1634609122967,"gmtModify":1634609543242,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>paypal","listText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>paypal","text":"$PayPal(PYPL)$paypal","images":[{"img":"https://static.tigerbbs.com/5ddf6f0129872de0980ee3e69c9a6573","width":"1242","height":"1968"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850562715","isVote":1,"tweetType":1,"viewCount":712,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":824221306,"gmtCreate":1634318561833,"gmtModify":1634318561957,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>Finally turn green&nbsp;","listText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>Finally turn green&nbsp;","text":"$PayPal(PYPL)$Finally turn green","images":[{"img":"https://static.tigerbbs.com/7c0a208f00ed1afe3babaa7bac16d04f","width":"1242","height":"1968"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824221306","isVote":1,"tweetType":1,"viewCount":734,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":828534890,"gmtCreate":1633923047535,"gmtModify":1633923047535,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"Nio&nbsp;","listText":"Nio&nbsp;","text":"Nio","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/828534890","repostId":"2174197480","repostType":2,"isVote":1,"tweetType":1,"viewCount":692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":828535405,"gmtCreate":1633922929428,"gmtModify":1633922929428,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"Good read&nbsp;","listText":"Good read&nbsp;","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/828535405","repostId":"2174979104","repostType":4,"isVote":1,"tweetType":1,"viewCount":867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862378722,"gmtCreate":1632840388214,"gmtModify":1632840388214,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>paypal","listText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>paypal","text":"$PayPal(PYPL)$paypal","images":[{"img":"https://static.tigerbbs.com/a27514ca216b616cb270a507c2c42f7f","width":"1242","height":"1968"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862378722","isVote":1,"tweetType":1,"viewCount":1354,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862362151,"gmtCreate":1632838321599,"gmtModify":1632838321599,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862362151","repostId":"1193693996","repostType":4,"repost":{"id":"1193693996","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632836938,"share":"https://www.laohu8.com/m/news/1193693996?lang=&edition=full","pubTime":"2021-09-28 21:48","market":"us","language":"en","title":"Pharmaceutical stocks slid in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1193693996","media":"Tiger Newspress","summary":"Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna and AstraZeneca f","content":"<p>Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna&nbsp;and&nbsp;AstraZeneca&nbsp;fell&nbsp;between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/bc8af8822165a8a89dc1b54a9195f782\" tg-width=\"398\" tg-height=\"729\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaceutical stocks slid in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaceutical stocks slid in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-28 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna&nbsp;and&nbsp;AstraZeneca&nbsp;fell&nbsp;between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/bc8af8822165a8a89dc1b54a9195f782\" tg-width=\"398\" tg-height=\"729\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来","AZN":"阿斯利康","NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc.","REGN":"再生元制药公司","BNTX":"BioNTech SE","PFE":"辉瑞","GILD":"吉利德科学"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193693996","content_text":"Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna and AstraZeneca fell between 1% and 7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":828535405,"gmtCreate":1633922929428,"gmtModify":1633922929428,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"Good read&nbsp;","listText":"Good read&nbsp;","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/828535405","repostId":"2174979104","repostType":4,"repost":{"id":"2174979104","kind":"highlight","pubTimestamp":1633922580,"share":"https://www.laohu8.com/m/news/2174979104?lang=&edition=full","pubTime":"2021-10-11 11:23","market":"us","language":"en","title":"3 Stocks Wall Street Thinks Will Soar 44% to 122% That You'll Want to Check Out","url":"https://stock-news.laohu8.com/highlight/detail?id=2174979104","media":"Motley Fool","summary":"These stocks are down but not out.","content":"<p>Imagine that you have a team of highly paid, highly educated analysts whose sole job is to evaluate stocks. Your analysts even do their best to project what price those stocks could attain over the next 12 months.</p>\n<p>Some of your analysts will be more optimistic than others. However, you get to look at an average of their price targets to help you pick stocks that could deliver especially attractive returns over the next year.</p>\n<p>The good news is that you don't have to use your imagination at all. Wall Street consensus price targets are readily available for many stocks. Here are three stocks Wall Street thinks will soar 44% to 121% that you'll definitely want to check out.</p>\n<h2>1. <a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></h2>\n<p>The average analyst's 12-month price target for <b>Trupanion</b> (NASDAQ:TRUP) reflects a 44% premium to the current share price. And the stock has proven already that it can reach that target level over the last 52 weeks.</p>\n<p>Trupanion ranks as the leading provider of medical insurance for cats and dogs in the U.S. and Canada. Its stock hasn't performed very well in recent months, mainly because the company didn't hit Wall Street's earnings estimates and its CEO sold some shares in September.</p>\n<p>Investors really don't have anything to worry about on either front, though. Trupanion continues to deliver strong growth, with revenue soaring 43% year over year in the second quarter. And while CEO Darryl Rawlings sold 8,000 shares last month, the sales were made under a previously scheduled Rule 10b5-1 trading plan. Rawlings still owns nearly 1 million shares of Trupanion.</p>\n<p>The company's long-term growth prospects remain as strong as ever. Only around 1% of all pets in the U.S. and 2% in Canada are covered by medical insurance. Trupanion doesn't have to increase that market penetration rate by much for its stock to be a huge winner for investors.</p>\n<h2>2. Novocure</h2>\n<p>Wall Street is even more bullish about&nbsp;<b>Novocure</b> (NASDAQ:NVCR). The consensus price target represents a potential upside of 56% for the healthcare stock.</p>\n<p>Novocure was flying high until July. Investors were disappointed with the company's results from a phase 2 study of its Tumor Treating Fields (TTFields) combined with sorafenib (chemotherapy) in treating advanced liver cancer. They also didn't think much of Novocure's Q2 results announced later in the month.</p>\n<p>But the company has plenty of other opportunities with TTFields, which are electric fields that can disrupt tumor cell division. The therapy has already been approved by the U.S. Food and Drug Administration (FDA) in treating brain cancer and mesothelioma. Novocure is evaluating TTFields in late-stage clinical studies targeting several types of cancer, including pancreatic cancer and non-small cell lung cancer -- two huge potential markets.</p>\n<h2>3. Skillz</h2>\n<p>Analysts have especially lofty sights for&nbsp;<b>Skillz</b> (NYSE:SKLZ). The average 12-month price target is 122% higher than the current share price. The most pessimistic of the analysts surveyed by Refinitiv think that Skillz stock could jump 52% higher.</p>\n<p>Like Trupanion and Novocure, Skillz has delivered a dismal stock performance so far this year. But its shares have fallen a lot more than the other two and are now down close to 80% below the highs set in February.</p>\n<p>The main problem for Skillz is that its monthly active users count is no longer growing. At the same time, advertising costs are rising, making it more expensive to attract new users. However, the company's recent acquisition of Aarki, which operates a demand-side advertising platform, could help on this front.</p>\n<p>Skillz also has other potential near-term growth drivers. It launched a mobile version of the popular old-school arcade game <i>Big Buck Hunter: Marksman</i>. The company is also working with the NFL to pick the winners in a competition to identify new NFL-branded mobile games.</p>\n<h2>What if the analysts are wrong?</h2>\n<p>Wall Street analysts can be -- and often are -- wrong. It's possible that none of these three stocks will hit their price targets. That's why you don't want to depend solely on analysts' estimates in choosing which stocks to buy.</p>\n<p>Of the three, my view is that Trupanion has the best chance of success. The company's software, which enables quick claim payments for veterinarians, gives it a significant competitive advantage.</p>\n<p>However, like Wall Street analysts, I could be wrong, too. There's no substitute for doing your own research before you buy any stock.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks Wall Street Thinks Will Soar 44% to 122% That You'll Want to Check Out</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks Wall Street Thinks Will Soar 44% to 122% That You'll Want to Check Out\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-11 11:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/10/3-stocks-wall-street-thinks-will-soar-44-to-122-th/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Imagine that you have a team of highly paid, highly educated analysts whose sole job is to evaluate stocks. Your analysts even do their best to project what price those stocks could attain over the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/10/3-stocks-wall-street-thinks-will-soar-44-to-122-th/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVCR":"NovoCure Limited","SKLZ":"Skillz Inc","TRUP":"Trupanion"},"source_url":"https://www.fool.com/investing/2021/10/10/3-stocks-wall-street-thinks-will-soar-44-to-122-th/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2174979104","content_text":"Imagine that you have a team of highly paid, highly educated analysts whose sole job is to evaluate stocks. Your analysts even do their best to project what price those stocks could attain over the next 12 months.\nSome of your analysts will be more optimistic than others. However, you get to look at an average of their price targets to help you pick stocks that could deliver especially attractive returns over the next year.\nThe good news is that you don't have to use your imagination at all. Wall Street consensus price targets are readily available for many stocks. Here are three stocks Wall Street thinks will soar 44% to 121% that you'll definitely want to check out.\n1. Trupanion\nThe average analyst's 12-month price target for Trupanion (NASDAQ:TRUP) reflects a 44% premium to the current share price. And the stock has proven already that it can reach that target level over the last 52 weeks.\nTrupanion ranks as the leading provider of medical insurance for cats and dogs in the U.S. and Canada. Its stock hasn't performed very well in recent months, mainly because the company didn't hit Wall Street's earnings estimates and its CEO sold some shares in September.\nInvestors really don't have anything to worry about on either front, though. Trupanion continues to deliver strong growth, with revenue soaring 43% year over year in the second quarter. And while CEO Darryl Rawlings sold 8,000 shares last month, the sales were made under a previously scheduled Rule 10b5-1 trading plan. Rawlings still owns nearly 1 million shares of Trupanion.\nThe company's long-term growth prospects remain as strong as ever. Only around 1% of all pets in the U.S. and 2% in Canada are covered by medical insurance. Trupanion doesn't have to increase that market penetration rate by much for its stock to be a huge winner for investors.\n2. Novocure\nWall Street is even more bullish about Novocure (NASDAQ:NVCR). The consensus price target represents a potential upside of 56% for the healthcare stock.\nNovocure was flying high until July. Investors were disappointed with the company's results from a phase 2 study of its Tumor Treating Fields (TTFields) combined with sorafenib (chemotherapy) in treating advanced liver cancer. They also didn't think much of Novocure's Q2 results announced later in the month.\nBut the company has plenty of other opportunities with TTFields, which are electric fields that can disrupt tumor cell division. The therapy has already been approved by the U.S. Food and Drug Administration (FDA) in treating brain cancer and mesothelioma. Novocure is evaluating TTFields in late-stage clinical studies targeting several types of cancer, including pancreatic cancer and non-small cell lung cancer -- two huge potential markets.\n3. Skillz\nAnalysts have especially lofty sights for Skillz (NYSE:SKLZ). The average 12-month price target is 122% higher than the current share price. The most pessimistic of the analysts surveyed by Refinitiv think that Skillz stock could jump 52% higher.\nLike Trupanion and Novocure, Skillz has delivered a dismal stock performance so far this year. But its shares have fallen a lot more than the other two and are now down close to 80% below the highs set in February.\nThe main problem for Skillz is that its monthly active users count is no longer growing. At the same time, advertising costs are rising, making it more expensive to attract new users. However, the company's recent acquisition of Aarki, which operates a demand-side advertising platform, could help on this front.\nSkillz also has other potential near-term growth drivers. It launched a mobile version of the popular old-school arcade game Big Buck Hunter: Marksman. The company is also working with the NFL to pick the winners in a competition to identify new NFL-branded mobile games.\nWhat if the analysts are wrong?\nWall Street analysts can be -- and often are -- wrong. It's possible that none of these three stocks will hit their price targets. That's why you don't want to depend solely on analysts' estimates in choosing which stocks to buy.\nOf the three, my view is that Trupanion has the best chance of success. The company's software, which enables quick claim payments for veterinarians, gives it a significant competitive advantage.\nHowever, like Wall Street analysts, I could be wrong, too. There's no substitute for doing your own research before you buy any stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862378722,"gmtCreate":1632840388214,"gmtModify":1632840388214,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>paypal","listText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>paypal","text":"$PayPal(PYPL)$paypal","images":[{"img":"https://static.tigerbbs.com/a27514ca216b616cb270a507c2c42f7f","width":"1242","height":"1968"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862378722","isVote":1,"tweetType":1,"viewCount":1354,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862362151,"gmtCreate":1632838321599,"gmtModify":1632838321599,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862362151","repostId":"1193693996","repostType":4,"repost":{"id":"1193693996","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632836938,"share":"https://www.laohu8.com/m/news/1193693996?lang=&edition=full","pubTime":"2021-09-28 21:48","market":"us","language":"en","title":"Pharmaceutical stocks slid in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1193693996","media":"Tiger Newspress","summary":"Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna and AstraZeneca f","content":"<p>Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna&nbsp;and&nbsp;AstraZeneca&nbsp;fell&nbsp;between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/bc8af8822165a8a89dc1b54a9195f782\" tg-width=\"398\" tg-height=\"729\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaceutical stocks slid in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaceutical stocks slid in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-28 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna&nbsp;and&nbsp;AstraZeneca&nbsp;fell&nbsp;between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/bc8af8822165a8a89dc1b54a9195f782\" tg-width=\"398\" tg-height=\"729\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来","AZN":"阿斯利康","NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc.","REGN":"再生元制药公司","BNTX":"BioNTech SE","PFE":"辉瑞","GILD":"吉利德科学"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193693996","content_text":"Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna and AstraZeneca fell between 1% and 7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850562715,"gmtCreate":1634609122967,"gmtModify":1634609543242,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>paypal","listText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>paypal","text":"$PayPal(PYPL)$paypal","images":[{"img":"https://static.tigerbbs.com/5ddf6f0129872de0980ee3e69c9a6573","width":"1242","height":"1968"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850562715","isVote":1,"tweetType":1,"viewCount":712,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":852316638,"gmtCreate":1635242090169,"gmtModify":1635242090285,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"Intel&nbsp;","listText":"Intel&nbsp;","text":"Intel","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852316638","repostId":"2178747335","repostType":4,"repost":{"id":"2178747335","kind":"news","pubTimestamp":1635234744,"share":"https://www.laohu8.com/m/news/2178747335?lang=&edition=full","pubTime":"2021-10-26 15:52","market":"us","language":"en","title":"Why Intel is in turnaround mode","url":"https://stock-news.laohu8.com/highlight/detail?id=2178747335","media":"Yahoo Finance","summary":"Chip giant Intel is in turnaround mode under CEO Pat Gelsinger, who is about eight months into the t","content":"<p>Chip giant Intel is in turnaround mode under CEO Pat Gelsinger, who is about eight months into the top job one he has said is his dream job at a company he started at when he was 18.</p>\n<p>As for why the storied 53-year-old chipmaker founded by tech titans Robert Noyce and Gordon Moore — which has long been seen as a leader in semiconductor making — is in a turnaround, Gelsinger (who returned in February after an 11-year run leading VMWare) points to several factors.</p>\n<p>\"I think over the decade there were some bad decisions. You know, lack of, I'll say, manic technology focus on the part of the company and more business leadership. Not that they were bad, but they were business leaders, they weren't technology leaders. Some stumbles around the process technology roadmap. Lack of clear leadership in the products. And under-investment in some of the key areas like our manufacturing and capacity,\" explained Gelsinger at Yahoo Finance's All Markets Summit.</p>\n<p>Added Gelsinger, \"So all of these sort of accumulated together to get the company to a position that it wasn't a leader. And it didn't have that sense of iconic leadership. The company that puts silicon into Silicon Valley.\"</p>\n<p>Gelsinger — an engineer by training who was mentored by Intel's legendary leader Andy Grove — wasted little time in trying to course correct Intel's future.</p>\n<p>In March, Intel quickly committed itself to making chips for other companies in a bid to increase industry capacity and help end the chip shortage. As part of that ambition, Intel recently broke ground on two chip making foundries in Arizona that are projected to cost $20 billion. Intel expects both plants — dubbed Fab 52 and Fab 62 — to be completed by 2024.</p>\n<p>Then in July, the supremely energetic Gelsinger outlined a new product roadmap for Intel that he believes will put it back in an industry leadership position by 2025.</p>\n<p>\"By 2025, we aren't talking about inching ahead of the competition but having miles between us and the competition,\" Gelsinger said.</p>\n<p>To be sure, Intel is still feeling the effects — which includes falling behind rivals <a href=\"https://laohu8.com/S/AMD\">AMD</a> and Nvidia in key chip technologies — of operational miscues by its prior leaders.</p>\n<p>Intel said last week that third quarter sales came in at $18.1 billion, slightly missing analyst forecasts for $18.24 billion. Sales at Intel's largest business — client computing — dropped 2% from a year ago. Data center sales rose 10% from last year. Autonomous driving tech outfit <a href=\"https://laohu8.com/S/MBLY\">Mobileye</a> saw sales gain 39%.</p>\n<p>Earnings per share tallied $1.71 compared to projections for $1.11.</p>\n<p>But Intel's outlook spooked investors, and they sent the stock down 11.5% on Friday.</p>\n<p>Intel told analysts on a conference it sees sales of at least $74 billion in 2022 (relatively in line with analysts). Gross margins are forecast in the 51% to 53% range for the next two to three years as Intel invests aggressively in its business. The Street had been estimating gross margins of 57%.</p>\n<p>\"We remain constructive on the long-term benefits of Intel’s turnaround efforts, but expect the stock to remain range-bound in the near-term until greater clarity on execution improvements become apparent,\" said Deutsche Bank analyst Ross Seymore.</p>\n<p>Seymore maintained a Hold rating on Intel's stock.</p>\n<p>Gelsinger acknowledges the skepticism on Wall Street about the pace of Intel's turnaround. But he remains steadfast that Intel is a different company today than when he took over, and that constructive change will only continue in the years to come.</p>\n<p>\"Intel is back, right. The geek is back. Our role — this deep, passionate view that we're going to deliver the best products. They're going to be high quality. We're going to scale them at volume. We're going to satisfy our customers better with them. And each one of these things is gaining momentum in the marketplace. So, you know, I look at our skeptics and I'll say just wait, right, because we're building the evidence base that is going to take the worst of skeptics today and turn them into the most ardent of believers tomorrow,\" Gelsinger says.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Intel is in turnaround mode</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Intel is in turnaround mode\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-26 15:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-intel-is-in-turnaround-mode-203942971.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chip giant Intel is in turnaround mode under CEO Pat Gelsinger, who is about eight months into the top job one he has said is his dream job at a company he started at when he was 18.\nAs for why the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-intel-is-in-turnaround-mode-203942971.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","MSFT":"微软","AMD":"美国超微公司","QCOM":"高通","AVGO":"博通","KLAC":"科磊","ASML":"阿斯麦","GOOGL":"谷歌A","AVGOP":"BROADCOM INC PFD SER A 22","AMZN":"亚马逊","INTC":"英特尔","MCHP":"微芯科技","GOOG":"谷歌","AAPL":"苹果"},"source_url":"https://finance.yahoo.com/news/why-intel-is-in-turnaround-mode-203942971.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2178747335","content_text":"Chip giant Intel is in turnaround mode under CEO Pat Gelsinger, who is about eight months into the top job one he has said is his dream job at a company he started at when he was 18.\nAs for why the storied 53-year-old chipmaker founded by tech titans Robert Noyce and Gordon Moore — which has long been seen as a leader in semiconductor making — is in a turnaround, Gelsinger (who returned in February after an 11-year run leading VMWare) points to several factors.\n\"I think over the decade there were some bad decisions. You know, lack of, I'll say, manic technology focus on the part of the company and more business leadership. Not that they were bad, but they were business leaders, they weren't technology leaders. Some stumbles around the process technology roadmap. Lack of clear leadership in the products. And under-investment in some of the key areas like our manufacturing and capacity,\" explained Gelsinger at Yahoo Finance's All Markets Summit.\nAdded Gelsinger, \"So all of these sort of accumulated together to get the company to a position that it wasn't a leader. And it didn't have that sense of iconic leadership. The company that puts silicon into Silicon Valley.\"\nGelsinger — an engineer by training who was mentored by Intel's legendary leader Andy Grove — wasted little time in trying to course correct Intel's future.\nIn March, Intel quickly committed itself to making chips for other companies in a bid to increase industry capacity and help end the chip shortage. As part of that ambition, Intel recently broke ground on two chip making foundries in Arizona that are projected to cost $20 billion. Intel expects both plants — dubbed Fab 52 and Fab 62 — to be completed by 2024.\nThen in July, the supremely energetic Gelsinger outlined a new product roadmap for Intel that he believes will put it back in an industry leadership position by 2025.\n\"By 2025, we aren't talking about inching ahead of the competition but having miles between us and the competition,\" Gelsinger said.\nTo be sure, Intel is still feeling the effects — which includes falling behind rivals AMD and Nvidia in key chip technologies — of operational miscues by its prior leaders.\nIntel said last week that third quarter sales came in at $18.1 billion, slightly missing analyst forecasts for $18.24 billion. Sales at Intel's largest business — client computing — dropped 2% from a year ago. Data center sales rose 10% from last year. Autonomous driving tech outfit Mobileye saw sales gain 39%.\nEarnings per share tallied $1.71 compared to projections for $1.11.\nBut Intel's outlook spooked investors, and they sent the stock down 11.5% on Friday.\nIntel told analysts on a conference it sees sales of at least $74 billion in 2022 (relatively in line with analysts). Gross margins are forecast in the 51% to 53% range for the next two to three years as Intel invests aggressively in its business. The Street had been estimating gross margins of 57%.\n\"We remain constructive on the long-term benefits of Intel’s turnaround efforts, but expect the stock to remain range-bound in the near-term until greater clarity on execution improvements become apparent,\" said Deutsche Bank analyst Ross Seymore.\nSeymore maintained a Hold rating on Intel's stock.\nGelsinger acknowledges the skepticism on Wall Street about the pace of Intel's turnaround. But he remains steadfast that Intel is a different company today than when he took over, and that constructive change will only continue in the years to come.\n\"Intel is back, right. The geek is back. Our role — this deep, passionate view that we're going to deliver the best products. They're going to be high quality. We're going to scale them at volume. We're going to satisfy our customers better with them. And each one of these things is gaining momentum in the marketplace. So, you know, I look at our skeptics and I'll say just wait, right, because we're building the evidence base that is going to take the worst of skeptics today and turn them into the most ardent of believers tomorrow,\" Gelsinger says.","news_type":1},"isVote":1,"tweetType":1,"viewCount":918,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858335995,"gmtCreate":1634976866832,"gmtModify":1634976866997,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"Good read&nbsp;","listText":"Good read&nbsp;","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/858335995","repostId":"853891088","repostType":1,"repost":{"id":853891088,"gmtCreate":1634785574941,"gmtModify":1634987426529,"author":{"id":"9000000000000419","authorId":"9000000000000419","name":"WallStreet_Tiger","avatar":"https://static.tigerbbs.com/eb8b72f48dd1c8d3451a5d8f8a51f42e","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000419","authorIdStr":"9000000000000419"},"themes":[],"title":"Top 10 Stocks Popular on WallStreetBets 10/21: PYPL Explores AcquisItion Of PINS","htmlText":"These&nbsp;10&nbsp;stocks&nbsp;are&nbsp;the&nbsp;most&nbsp;popular&nbsp;on&nbsp;WallStreetBets&nbsp;for&nbsp;the&nbsp;last&nbsp;24&nbsp;hours: <a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a> posted third-quarter profitsthat topped expectations, with record deliveries helping fuel the electric-vehicle maker's results even as supply chain challenges weighed broadly on the auto industry. However, quarterly revenue came in short of consensus expectations, and shares fell slightly in after-hours trading.&nbsp; <a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a> has offered to buy digital pinboard site Pinterest Inc&nbsp;<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a> for $45 billion, according&nbsp;to&nbsp;the&nbsp;report on Wednesday, a combination that could he","listText":"These&nbsp;10&nbsp;stocks&nbsp;are&nbsp;the&nbsp;most&nbsp;popular&nbsp;on&nbsp;WallStreetBets&nbsp;for&nbsp;the&nbsp;last&nbsp;24&nbsp;hours: <a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a> posted third-quarter profitsthat topped expectations, with record deliveries helping fuel the electric-vehicle maker's results even as supply chain challenges weighed broadly on the auto industry. However, quarterly revenue came in short of consensus expectations, and shares fell slightly in after-hours trading.&nbsp; <a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a> has offered to buy digital pinboard site Pinterest Inc&nbsp;<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a> for $45 billion, according&nbsp;to&nbsp;the&nbsp;report on Wednesday, a combination that could he","text":"These 10 stocks are the most popular on WallStreetBets for the last 24 hours: $Tesla Motors(TSLA)$ posted third-quarter profitsthat topped expectations, with record deliveries helping fuel the electric-vehicle maker's results even as supply chain challenges weighed broadly on the auto industry. However, quarterly revenue came in short of consensus expectations, and shares fell slightly in after-hours trading. $PayPal(PYPL)$ has offered to buy digital pinboard site Pinterest Inc $Pinterest, Inc.(PINS)$ for $45 billion, according to the report on Wednesday, a combination that could he","images":[{"img":"https://static.tigerbbs.com/42d3767093c342b8608d28d9df362c09","width":"-1","height":"-1"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/853891088","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824221306,"gmtCreate":1634318561833,"gmtModify":1634318561957,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>Finally turn green&nbsp;","listText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>Finally turn green&nbsp;","text":"$PayPal(PYPL)$Finally turn green","images":[{"img":"https://static.tigerbbs.com/7c0a208f00ed1afe3babaa7bac16d04f","width":"1242","height":"1968"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824221306","isVote":1,"tweetType":1,"viewCount":734,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":828534890,"gmtCreate":1633923047535,"gmtModify":1633923047535,"author":{"id":"4090586973979210","authorId":"4090586973979210","name":"Sam94","avatar":"https://static.tigerbbs.com/344e49704ffcb7711b7d80b7367aede3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090586973979210","authorIdStr":"4090586973979210"},"themes":[],"htmlText":"Nio&nbsp;","listText":"Nio&nbsp;","text":"Nio","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/828534890","repostId":"2174197480","repostType":2,"isVote":1,"tweetType":1,"viewCount":692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}